PRP Therapy
(Platelet-Rich Plasma)
Concentrated growth factors from your own blood, injected directly into the erectile tissue. Minimally invasive, autologous, and explicitly positioned as experimental.
How does PRP work?
From a small amount of blood, platelets are concentrated. These platelets contain growth factors: VEGF, PDGF, FGF and EGF, which are injected under local anaesthesia into the penile tissue.
Neovascularisation
VEGF stimulates the formation of new blood vessels, structurally improving blood flow to the erectile tissue.
Stem cell activation
Growth factors mobilise endogenous stem cells to the treated area, contributing to tissue regeneration.
Vessel wall function
PDGF and FGF promote the integrity and elasticity of the vessel wall. Essential for adequate blood flow.
Smooth muscle tissue
EGF supports the repair of smooth muscle tissue in the corpora cavernosa, necessary for retaining blood during an erection.
Four steps, one session
The complete PRP procedure takes place in a single visit. No hospital admission, no recovery period.
Sessions and duration
The number of sessions depends on your indication and response. Every session is performed personally by the physician.
Minimal risks, maximum transparency
PRP is autologous: it is prepared from your own blood. This means there is no risk of allergic reaction or rejection.
Autologous material
No foreign material. Your own platelets, your own growth factors. No risk of allergic reaction or rejection.
Minimally invasive
Injection under local anaesthesia. No surgery, no general anaesthesia. You go home after the session with just 24 hours of rest.
Performed by the physician
The PRP injection is always performed personally by the registered physician. Not by a nurse or assistant.
What the evidence says, honestly
We believe you should know the scientific state of affairs before making a decision.
Improvement in the PRP group versus 27% in the placebo group. Poulios et al. (2021), the most cited study on PRP for erectile problems.
The EAU currently classifies PRP for ED as experimental. We treat it that way too.
- Why is PRP still experimental?There are promising results from smaller studies, but large, double-blind RCTs are still lacking. The EAU is waiting for more data before classifying PRP as proven.
- Why do you offer it then?Because the initial data are promising, the safety profile is favourable (autologous material), and some patients may benefit from a combined approach. But only after comprehensive informed consent and selective indication.
- How do you know if it works for me?We measure at baseline and at 1, 3, 6 and 12 months. With validated questionnaires and the same measurement criteria. If it doesn't work, we see that and act accordingly.
Who is PRP most suitable for?
PRP is not the right choice for everyone. We are selective in our indications.
Suitable candidates
- Mild to moderate vasculogenicSHIM score 8-21. The group for which the initial data are most promising.
- Preferably under 45Younger patients show a stronger response to PRP in the available studies.
- Symptoms for less than 2 yearsThe earlier in the process, the greater the chance that regenerative therapy will be effective.
Less suitable
- Severe ED (SHIM <8)With very severe symptoms, the chance of clinically relevant improvement with PRP alone is too limited.
- Neurogenic causeIf the erectile problems are primarily nerve-related, PRP is not the right indication.
- Uncontrolled diabetes or post-prostatectomyFor uncontrolled diabetes or after a radical prostatectomy, the expected effect of PRP is insufficiently supported.